AurKa Pharma Inc., based in Montréal, Québec, is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Ventures VII. AurKa Pharma Inc. plans to develop, to proof-of-concept, a compound originally discovered through one of Eli Lilly and Company’s (Lilly) research and development programs, with the potential to treat certain types of solid tumors, inc...
AurKa Pharma Inc., based in Montréal, Québec, is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Ventures VII. AurKa Pharma Inc. plans to develop, to proof-of-concept, a compound originally discovered through one of Eli Lilly and Company’s (Lilly) research and development programs, with the potential to treat certain types of solid tumors, including small cell lung cancer and treatment resistant breast cancer.
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.